Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AMBIEN safely and effectively. See full prescribing information for AMBIEN Ambien® (zolpidem tartrate) tablets CIVInitial U.S. Approval: 1992
Medication labelWhy this: Advisory · dailymed-prescription
Ambien (zolpidem tartrate) is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Ambien has been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies (14)]. The clinical trials performed in support of efficacy were 4–5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.
- generic_name
- zolpidem tartrate
- product_names
- ZOLPIDEM TARTRATE
- ndc
- 16590-009, 16590-010, 0024-5401, 16590-009-20, 16590-009-30, 16590-009-60, 16590-009-90, 0024-5421, 16590-010-20, 16590-010-28, 16590-010-30, 16590-010-56
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en